Karachi: GlaxoSmithKline Pakistan Limited has announced a virtual Corporate Briefing Session (CBS) scheduled for December 8, 2025, from 10 am to 11 am. The session, to be held via Microsoft Teams, will feature senior management briefing investors, analysts, and shareholders on the company’s operational developments and performance.

According to information available from the Pakistan Stock Exchange (PSX), the presentation pertaining to the CBS will be made accessible on PUCARs and the company’s website by December 5, 2025. The session aims to provide detailed insights into the company’s recent initiatives and strategic direction, aligning with PSX Notice No. PSX/N-1120, dated November 2, 2023.

Participants are advised to join the meeting 10 minutes prior to the start time. The meeting details are as follows: Meeting ID 218 087 472 539 96 and Passcode JX2Sa79n. During the presentation, participants should remain on mute, while questions can be typed in Vevox or indicated by raising a hand in the participant list. The company will address these queries after the presentation concludes.

The designated market category for this announcement remains focused on providing transparency and engagement with stakeholders, ensuring comprehensive coverage of the company’s financial and operational performance.